DNDN: Summary for Dendreon Corporation - Yahoo! Canada Finance

MORE ON DNDN

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Dendreon Corporation (NGM:DNDN) Delayed quote data

Last Trade:	29.44 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	29.44
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	36.44

Day's Range:	N/A - N/A
52wk Range:	2.55 - 30.90
Volume:	0
Avg Vol (3m):	2,244,100
Market Cap:	3.41B
P/E (ttm):	N/A
EPS (ttm):	-1.92
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add DNDN to Portfolio

Download Data

HEADLINES

•	This Stock Has Tremendous Upside
	at Motley Fool (Tue 1:30pm)

•	5-Star Stocks Poised to Pop: ISTA Pharmaceuticals
	at Motley Fool (Tue 9:44am)

•	An Earnings Surprise of an Unusual Kind
	at Motley Fool (Mon, Feb 8)

•	4 Winning Biotechs For Your Portfolio: Senior Analyst
	at CNBC (Mon, Feb 8)

•	Is Biotech Back?
	CNBC (Mon, Feb 8)

•	[video] Is Biotech Back?
	at CNBC (Mon, Feb 8)

•	There's No Such Thing as an ETF Bubble
	at TheStreet.com (Mon, Feb 8)

•	4-Star Stocks Poised to Pop: Myriad Genetics
	at Motley Fool (Thu, Feb 4)

•	Dendreon Announces Webcast Presentation at 12th Annual BIO CEO and Investor Conference
	PRNewswire (Wed, Feb 3)

•	Ground Floor -- Going Up!
	at Motley Fool (Tue, Feb 2)

•	Dendreon: To Short or Not to Short?
	at Seeking Alpha (Tue, Feb 2)

•	Barron's: new drugs could help industry sales, shares
	at Reuters (Sun, Jan 31)

More Headlines for DNDN...

ANALYST

EPS Est (next year) (Dec-09) :	-1.71
EPS Est (in 2 years) (Dec-10) :	-0.60
Avg Rec (current)*:	1.5
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Dendreon Corp. (DNDN)